We are live on
!
Find out more
Iovance Biotherapeutics
IOVA
IOVA
200 hedge funds and large institutions have $3.44B invested in Iovance Biotherapeutics in 2019 Q4 according to their latest regulatory filings, with 45 funds opening new positions, 75 increasing their positions, 60 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
573% more call options, than puts
Call options by funds: $62.1M | Put options by funds: $9.22M
246% more first-time investments, than exits
New positions opened: 45 | Existing positions closed: 13
53% more capital invested
Capital invested by funds: $2.25B → $3.44B (+$1.19B)
25% more funds holding in top 10
Funds holding in top 10: 8 → 10 (+2)
25% more repeat investments, than reductions
Existing positions increased: 75 | Existing positions reduced: 60
16% more funds holding
Funds holding: 173 → 200 (+27)
1.31% less ownership
Funds ownership: 99.69% → 98.38% (-1.3%)
Holders
200
Holders Change
+27
Holders Change %
+15.61%
% of All Funds
3.94%
Holding in Top 10
10
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+25%
% of All Funds
0.2%
New
45
Increased
75
Reduced
60
Closed
13
Calls
$62.1M
Puts
$9.22M
Net Calls
+$52.8M
Net Calls Change
+$28M
Top Buyers
Top Sellers
| 1 |
ACA
Avoro Capital Advisors
New York
|
-$40.4M |
| 2 |
PA
Perceptive Advisors
New York
|
-$36.4M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$24.8M |
| 4 |
BC
Broadfin Capital
New York
|
-$13.6M |
| 5 |
State Street
Boston,
Massachusetts
|
-$9.87M |
